The study in this thread is what you are talking about: Malaysian Study Finds Ivermectin ‘Did Not Prevent’ Severe COVID-19, but Doctors Alliance Calls It ‘Misleading’. This study used a dose of Ivermectin no one is advocating on patients with mild to severe cases and found that major side effects were the same. The 70% reduction in death was not important.
The study in the WSJ article about people who were at risk of a severe case of Covid. So this looks like it was set up to ensure failure of what no one is calling for.
Like I said, wicked sneaky devils as always, setting up the fail. If fat in the stomach helps transport the drug, they make sure the trial participants have none.
“Furthermore, no qualified physician or scientist recommends treating COVID-19 with the low dosage of ivermectin used in the trial, nor treating a patient with ivermectin for only three days on an empty stomach, as TOGETHER did. FLCCC physicians have understood for nearly 18 months that ivermectin works best against COVID-19 when administered with a fatty meal “